Thomas P. Leist, MD, PhD, FAAN
Professor
Division Chief, Multiple Sclerosis/Neuroimmunology
Fellowship Program Director, Multiple Sclerosis/Neuroimmunology
Contact Information
900 Walnut Street
Second Floor
Philadelphia, PA 19107
215-955-6871
215-503-2990 fax
Professor
Division Chief, Multiple Sclerosis/Neuroimmunology
Fellowship Program Director, Multiple Sclerosis/Neuroimmunology
Education
Medical School
MD, University of Miami School of Medicine
PhD, University of Zurich, Switzerland
Residency
Cornell Medical Center
Fellowship
National Institute of Health
UCLA
Univesity of Zurich, Switzerland
Publications
- Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort
- Revealing the immune cell subtype reconstitution profile in patients from the CLARITY study using deconvolution algorithms after cladribine tablets treatment
- A plain language summary on assessing the long-term effectiveness of cladribine tablets in people living with relapsing multiple sclerosis: The CLASSIC-MS study
- A retrospective claims analysis of fatigue in patients with multiple sclerosis on disease-modifying therapy
- Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial
Board Certification
American Board of Psychiatry & Neurology
Hospital Appointment
Thomas Jefferson University Hospital